Quick Answer
TransMedics Group, Inc. reported Diluted EPS of $4.87 per share for fiscal year 2025.
TransMedics Group, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $4.87 | +382.2% |
| 2024 | $1.01 | +231.2% |
| 2023 | -$0.77 | +37.4% |
| 2022 | -$1.23 | +23.1% |
| 2021 | -$1.60 | -37.9% |
| 2020 | -$1.16 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.66 | +450.0% | -28.3% |
| June 30, 2025 | $0.92 | +162.9% | +31.4% |
| March 31, 2025 | $0.70 | +100.0% | +483.3% |
| September 30, 2024 | $0.12 | +115.4% | -65.7% |
| June 30, 2024 | $0.35 | +1266.7% | +0.0% |
| March 31, 2024 | $0.35 | +537.5% | +144.9% |
| September 30, 2023 | -$0.78 | -212.0% | -2500.0% |
| June 30, 2023 | -$0.03 | +92.7% | +62.5% |
- TransMedics Group, Inc. showed an increase of +382.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, TransMedics Group, Inc.’s diluted eps has grown by 519.8% (from $1.16 per share (loss) to $4.87 per share).
- The most recent figure is from TransMedics Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: